Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.36USD
1 Jul 2013
Price Change (% chg)

$0.18 (+2.20%)
Prev Close
$8.18
Open
$8.17
Day's High
$8.49
Day's Low
$8.17
Volume
1,430,173
Avg. Vol
1,113,949
52-wk High
$11.36
52-wk Low
$5.42

ACHN.O

Chart for ACHN.O

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the... (more)

Overall

Beta: 0.65
Market Cap (Mil.): $807.21
Shares Outstanding (Mil.): 96.56
Dividend: --
Yield (%): --

Financials

  ACHN.O Industry Sector
P/E (TTM): -- 34.05 33.02
EPS (TTM): -0.64 -- --
ROI: -38.28 -2.50 19.07
ROE: -38.40 -3.10 20.00
Search Stocks

Latest News about ACHN.O

UPDATE 1-FDA places clinical hold on Achillion's hep C drug, shares plunge

* Co says liver enzymes elevated in drug interaction with HIV drug

01 Jul 2013

FDA places clinical hold on Achillion's hepatitis C drug

July 1 - Achillion Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on its hepatitis C drug sovaprevir after elevations in liver enzymes were noted in an early-stage study of the drug's interaction with an HIV drug.

01 Jul 2013
» More ACHN.O News

Competitors

  Price Change
Pfizer Inc. (PFE.N) $27.78 -0.23
Johnson & Johnson (JNJ.N) $86.63 +0.77
Novartis AG (NOVN.VX) CHF67.15 -0.15
Merck & Co., Inc. (MRK.N) $46.32 -0.13
Roche Holding Ltd. (ROG.VX) CHF234.00 -0.60
Abbott Laboratories (ABT.N) $35.03 +0.15
AstraZeneca plc (AZN.L) 3,156.50p +5.50
GlaxoSmithKline plc (GSK.L) 1,660.00p +1.50
Bristol Myers Squibb Co. (BMY.N) $44.82 +0.13
Bristol Myers Squibb Co. (BMYMP.PK) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - ACHILLION PHARMACEUTICALS, INC. (ACHN-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Market Edge Equity Research Report
Provider: Market Edge
$10.00
Buy
Achillion Pharmaceuticals
Provider: S&P Capital IQ Quantitative Report
$69.00
Buy
ACHILLION PHARMACEUTICALS INC (ACHN) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Achillion Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks